<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48-pathogens-09-00148">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Both</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>van Dolleweerd</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wright</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Banyard</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Bulmer-Thomas</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Selden</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Altmann</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Fooks</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>J.K.</given-names>
   </name>
  </person-group>
  <article-title>Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans</article-title>
  <source>FASEB J.</source>
  <year>2013</year>
  <volume>27</volume>
  <fpage>2055</fpage>
  <lpage>2065</lpage>
  <pub-id pub-id-type="doi">10.1096/fj.12-219964</pub-id>
  <?supplied-pmid 23371065?>
  <pub-id pub-id-type="pmid">23371065</pub-id>
 </element-citation>
</ref>
